Status, Trials & Timeline (2026)
Some agents in this class (liraglutide, semaglutide, and dulaglutide) have demonstrated cardiovascular benefits in patients with established cardiovascular disease, while exenatide showed a neutral effect in cardiovascular outcome trials
The enrollment process step by step Getting started with Willow follows a fully digital workflow
In combination, the two drugs work in the brain to reduce appetite and food cravings, which can help people lose weight
The faster onset with Retatrutide does come with some considerations
The GLP-1RA group reported lower subjective feelings of intoxication during the early timepoints of the session, as indicated by reduced ratings on the Visual Analog Scale (VAS) for How drunk do you feel?